Cholesterol as a risk factor for dementia and cognitive decline: A systematic review of prospective studies with meta-analysis

American Journal of Geriatric Psychiatry

Volumn 16, Issue 5, 2008, Pages 343-354

  Anstey, Kaarin J ^a   Lipnicki, Darren M ^a   Low, Lee Fay ^b  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Alzheimer disease; APOE; lipoprotein; mild cognitive impairment; systematic review; vascular dementia

Indexed keywords

APOLIPOPROTEIN E4; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ALLELE; ALZHEIMER DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COGNITIVE DEFECT; DEMENTIA; FOLLOW UP; HUMAN; MILD COGNITIVE IMPAIRMENT; MULTIINFARCT DEMENTIA; PROSPECTIVE STUDY; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; TRIACYLGLYCEROL BLOOD LEVEL; AGED; AGING; ARTICLE; BLOOD; META ANALYSIS; MIDDLE AGED; PATIENT SELECTION; PHYSIOLOGY; REPRODUCIBILITY;

AGED; AGING; CHOLESTEROL; COGNITION DISORDERS; DEMENTIA; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; PATIENT SELECTION; REPRODUCIBILITY OF RESULTS; RISK FACTORS;

EID: 48649110601     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/01.JGP.0000310778.20870.ae     Document Type: Review

References (53)

1. Whalley LJ, Dick FD, McNeill G: A life-course approach to the aetiology of late-onset dementias. Lancet Neurol 2006; 5:87-96
2. Panza F, D'Introno A, Colacicco AM, et al: Cognitive frailty: predementia syndrome and vascular risk factors. Neurobiol Aging 2006; 27:933-940
3. Panza F, D'Introno A, Colacicco AM, et al: Lipid metabolism in cognitive decline and dementia. Brain Res Rev 2006; 51:275-292
4. Launer LJ: The epidemiologic study of dementia: a life-long quest? Neurobiol Aging 2005; 26:335-340
5. Kivipelto M, Solomon A: Cholesterol as a risk factor for Alzheimer's disease - epidemiological evidence. Acta Neurol Scand Suppl 2006; 185:50-57
6. Hofer SM, Sliwinski MJ: Understanding ageing. An evaluation of research designs for assessing the interdependence of ageing-related changes. Gerontology 2001; 47:341-352
7. Qiu C, Winblad B, Fratiglioni L: The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 2005; 4:487-499
8. Braak H, Braak E: Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991; 82:239-259
9. Anstey KJ, von Sanden C, Salim A, et al: Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am J Epidemiol 2007; 166:367-378
10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd Revised. Ed. Washington, DC, American Psychiatric Association, 1987
11. McKhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-944
12. Roman GC, Tatemichi TK, Erkinjuntti T, et al: Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993; 43:250-260
13. Petersen RC, Smith GE, Ivnik RJ, et al: Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA 1995; 273:1274-1278
14. de Craen AJ, Gussekloo J, Vrijsen B, et al: Meta-analysis of nonsteroidal antiinflammatory drug use and risk of dementia. Am J Epidemiol 2005; 161:114-120
15. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. Vol Issue 3. Chichester, UK, John Wiley & Sons, 2005
16. Bernick C, Katz R, Smith NL, et al: Statins and cognitive function in the elderly: the Cardiovascular Health Study. Neurology 2005; 65:1388-1394
17. Cervilla JA, Prince M, Mann A: Smoking, drinking, and incident cognitive impairment: a cohort community based study included in the Gospel Oak project. J Neurol Neurosurg Psychiatry 2000; 68:622-626
18. Kalmijn S, Launer LJ, Ott A, et al: Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol 1997; 42:776-782
19. Prince M, Lovestone S, Cervilla J, et al: The association between APOE and dementia does not seem to be mediated by vascular factors. Neurology 2000; 54:397-402
20. Rea TD, Breitner JC, Psaty BM, et al: Statin use and the risk of incident dementia: the Cardiovascular Health Study. Arch Neurol 2005; 62:1047-1051
21. Zimetbaum P, Frishman WH, Ooi WL, et al: Plasma lipids and lipoproteins and the incidence of cardiovascular disease in the very elderly. The Bronx Aging Study. Arterioscler Thromb 1992; 12:416-423
22. Moroney JT, Tang MX, Berglund L, et al: Low-density lipoprotein cholesterol and the risk of dementia with stroke. JAMA 1999; 282:254-260
23. Romas SN, Tang MX, Berglund L, et al: APOE genotype, plasma lipids, lipoproteins, and AD in community elderly. Neurology 1999; 53:517-521
24. Tan ZS, Seshadri S, Beiser A, et al: Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study. Arch Intern Med 2003; 163:1053-1057
25. Kivipelto M, Helkala EL, Laakso MP, et al: Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann Intern Med 2002; 137:149-155
26. Notkola IL, Sulkava R, Pekkanen J, et al: Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology 1998; 17:14-20
27. Stewart R, White LR, Xue QL, et al: Twenty-six-year change in total cholesterol levels and incident dementia: the Honolulu-Asia Aging Study. Arch Neurol 2007; 64:103-107
28. Li G, Shofer JB, Kukull WA, et al: Serum cholesterol and risk of Alzheimer disease: a community-based cohort study. Neurology 2005; 65:1045-1050
29. Reitz C, Tang MX, Luchsinger J, et al: Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch Neurol 2004; 61:705-714
30. Slooter AJC, Ruitenberg A, van Duijn CM, et al: The effect of apoE on dementia is not through atherosclerosis: The Rotterdan Study: Reply. Neurology 2000; 54:2357-2358
31. Beeri MS, Rapp M, Silverman JM, et al: Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers. Neurology 2006; 66:1399-1404
32. Mielke MM, Zandi PP, Sjogren M, et al: High total cholesterol levels in late life associated with a reduced risk of dementia. Neurology 2005; 64:1689-1695
33. Kivipelto M, Helkala EL, Laakso MP, et al: Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 2001; 322:1447-1451
34. Solfrizzi V, Panza F, Colacicco AM, et al: Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology 2004; 63:1882-1891
35. Yoshitake T, Kiyohara Y, Iwamoto H, et al: Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: The Hisayama Study. Neurology 1995; 45:1161-1168
36. Kalmijn S, Feskens EJ, Launer LJ, et al: Cerebrovascular disease, the apolipoprotein e4 allele, and cognitive decline in a community-based study of elderly men. Stroke 1996; 27:2230-2235
37. Reitz C, Luchsinger J, Tang MX, et al: Impact of plasma lipids and time on memory performance in healthy elderly without dementia. Neurology 2005; 64:1378-1383
38. Hyman BT, Gomez-Isla T, Briggs M, et al: Apolipoprotein E and cognitive change in an elderly population. Ann Neurol 1996; 40:55-66
39. Whitmer RA, Sidney S, Selby J, et al: Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 2005; 64:277-281
40. Kalmijn S, Foley D, White L, et al: Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study. Arterioscler Thromb Vasc Biol 2000; 20:2255-2260
41. Kuusisto J, Koivisto K, Mykkanen L, et al: Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study. BMJ 1997; 315:1045-1049
42. Wada T, Matsubayashi K, Okumiya K, et al: Lower serum cholesterol level and later decline in cognitive function in older people living in the community, Japan. J Am Geriatr Soc 1997; 45:1411-1412
43. Swan GE, LaRue A, Carmelli D, et al: Decline in cognitive performance in aging twins. Heritability and biobehavioral predictors from the National Heart, Lung, and Blood Institute Twin Study. Arch Neurol 1992; 49:476-481
44. Borroni B, Grassi M, Costanzi C, et al: APOE genotype and cholesterol levels in lewy body dementia and Alzheimer disease: investigating genotype-phenotype effect on disease risk. Am J Geriatr Psychiatry 2006; 14:1022-1031
45. Solomon A, Kareholt I, Ngandu T, et al: Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study. Neurology 2007; 68:751-756
46. Chiang CJ, Yip PK, Wu SC, et al: Midlife risk factors for subtypes of dementia: A Nested Case-Control Study in Taiwan. Am J Geriatr Psychiatry 2007; 15:762-771
47. Monastero R, Palmer K, Qiu C, et al: Heterogeneity in risk factors for cognitive impairment, no dementia: population-based longitudinal study from the Kungsholmen Project. Am J Geriatr Psychiatry 2007; 15:60-69
48. Zuliani G, Volpatol S, Romagnoni F, et al: Combined measurement of serum albumin and high-density lipoprotein cholesterol strongly predicts mortality in frail older nursing-home residents. Aging Clin Exp Res 2004; 16:472-475
49. Almeida OP, Flicker L, Norman P, et al: Association of cardiovascular risk factors and disease with depression in later life. Am J Geriatr Psychiatry 2007; 15:506-513
50. Jick H, Zornberg GL, Jick SS, et al: Statins and the risk of dementia. Lancet 2000; 356:1627-1631
51. Shea BJ, Grimshaw JM, Wells GA, et al: Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol 2007; 7:10
52. Karlamangla AS, Singer BH, Reuben DB, et al: Increases in serum non-high-density lipoprotein cholesterol may be beneficial in some high-functioning older adults: MacArthur studies of successful aging.[see comment]. J Am Geriatr Soc 2004; 52:487-494
53. Kivipelto M, Helkala EL, Hanninen T, et al: Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study. Neurology 2001; 56:1683-1689